Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Action Needed Now To Stop NHS Wales Becoming Unsafe For Staff And Patients - Says British Medical Association Cymru Wales
Doctors" leaders are warning that unless urgent action is taken to plug the gap in the shortage of middle grade doctors, the NHS in Wales could become unsafe both for staff and patients.

Lobbying Groups Prepare For Reconciliation Process, Step Up Fight On Bill Features
Lobbyists are beginning to consider how their clients would fare if health reform moves to a reconciliation process to pass legislation, Roll Call reports. "As the health care debate has grown increasingly partisan, lobbyists say they are taking more seriously the looming possibility of having many reforms added to reconciliation. "I think almost everyone looks at reconciliation as a last resort," said John Rother, executive vice president of policy and strategy for the seniors" lobby AARP. "But we haven"t made a lot of progress. Patience is running thin."" A bill passed by reconciliation would need only 51 Senate votes instead of the filibuster-proof usual 60.
News of the day
White House Remains Open To Taxing Health Benefits, Obama Plans Town Hall Meeting
The White House remains open to taxing some health benefits to help pay for health care reform despite campaigning against the move last year, The Washington Post reports.
Mental Health

No More Test Tubes On Four Feet? EPA Moves Toward Animal-free Toxicity Tests

The U.S. Environmental Protection Agency (EPA) plans to switch to a new generation of animal-free tests for predicting the toxicity of chemicals to humans, according to an article scheduled for the June 22 issue of Chemical & Engineering News, ACS" weekly newsmagazine. C&EN associate editor Britt Erickson points out that there are more than 80,000 chemicals on the market, with about 700 more added each year. Over the next ten years, EPA plans to increasingly rely on so-called toxicity-based pathways to evaluate these substances. This approach involves using human cell cultures to screen newly marketed chemicals for adverse effects. The new tests will produce results in a fraction of the time now required with animal studies. But the switch won"t be easy, the C&EN article notes. Some experts question the validity of these next-generation tests. Meanwhile, new technologies for predicting toxicity may emerge and complement conventional animal tests, according to the article. American Chemical Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009